20 results
8-K
EX-10.2
TXMD
TherapeuticsMD Inc
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
by the words “without limitation;”
(f) references herein to any gender shall include each other gender;
(g) with respect to the determination of any period
8-K
EX-10.1
TXMD
TherapeuticsMD Inc
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
) references herein to any gender shall include each other gender;
(g) with respect to the determination of any period of time, the word “from” means “from
8-K
EX-2.1
oj5wthgby2s4jg512l21
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-2.1
ps9w9m5wmn4ld v6
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-99.2
z36xl8728 4xl8ji4fo
2 Mar 21
TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results
7:00am
8-K/A
EX-10.10
nabyvm
9 Dec 11
Financial Statements and Exhibits
12:00am
8-K
EX-10.6
5ujmyt
24 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.01
kvvfq7u0r1ztdjztl
21 Jul 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.02
9972q8lz8
30 Jul 09
Index to Financial Statements
12:00am
- Prev
- 1
- Next